Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia (Q35615823)
Jump to navigation
Jump to search
scientific article published on 26 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia |
scientific article published on 26 September 2006 |
Statements
1 reference
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia (English)
1 reference
Larry J Schaaf
1 reference
John C Byrd
1 reference
Nyla A Heerema
1 reference
James T Dalton
1 reference
Kristie A Blum
1 reference
Michael R Grever
1 reference
Mitch A Phelps
1 reference
Gerard Lozanski
1 reference
Mollie Moran
1 reference
Thomas S Lin
1 reference
Michelle Brooker-McEldowney
1 reference
Sarah Broering
1 reference
Donn C Young
1 reference
Di Wu
1 reference
Beth Fischer
1 reference
Brad Rovin
1 reference
Amy J Johnson
1 reference
David M Lucas
1 reference
Jose-Ramon Suarez
1 reference
A Dimitrios Colevas
1 reference
26 September 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference